Hip Arthroscopy Postoperative Opioid Demands

Description

This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.

Conditions

Opioid Use, Pain, Femoral Acetabular Impingement, Labral Tear, Glenoid

Study Overview

Study Details

Study overview

This study will be a prospective, single-blinded, randomized controlled trial (RCT), investigating the influence of the number of opioid pills prescribed following primary hip arthroscopy. All patients who sign the consent form will be enrolled in the suited and randomized to one of the two treatment arms. The intervention group will receive 5 Norco pills, gabapentin (30 mg, once daily for 10 days following surgery), and Tylenol (1000 mg, three times daily for 10 days following surgery) while the control will receive the standard at our practice of 30 Norco pills.

Randomized Control Trial Evaluating Postoperative Opioid Demands Following Hip Arthroscopy

Hip Arthroscopy Postoperative Opioid Demands

Condition
Opioid Use
Intervention / Treatment

-

Contacts and Locations

Chicago

Rush University Medical Center, Chicago, Illinois, United States, 60612

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult patients age 18-80 years
  • * English speaking
  • * Opioid naive patient (defined as not taking opioid pills within 6 weeks prior to surgery), confirmed by checking the Illinois Prescription monitoring program
  • * Primary hip arthroscopy
  • * Written and informed consent for study participation
  • * Minors (\<18 years of age)
  • * Opioid tolerant patients
  • * Revision surgery
  • * Prior infections of the operative joint
  • * History of active malignancy within the past 5 years
  • * Chronic pain conditions including low back pain, chronic pain syndrome, fibromyalgia
  • * History of alcohol or other substance use disorder
  • * Other disease states including rheumatologic conditions, diabetes mellitus, hypo/hyperthyroidism, depression, anxiety
  • * Grade IV chondral defects

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Rush University Medical Center,

Study Record Dates

2026-03